Our accredited content is designed to impact patient health outcomes, by ensuring that it provides you with a learning experience that will positively impact your clinical practice, based on adult learning preferences and intuitive instructional design. All activities are developed in collaboration with leading faculty and education partners.
Watch breast cancer oncologists discuss the role of ADCs in the treatment of metastatic breast cancer.
Three experts discuss IO approaches for the treatment of patients with triple-negative breast cancer.
Expert insights on the practical application of immunotherapy in early-stage NSCLC
Watch an expert discuss the key clinical questions surrounding currently approved RET inhibitors in NSCLC.
Watch breast cancer oncologists discuss the role of ADCs in the treatment of metastatic breast cancer.
Three experts discuss IO approaches for the treatment of patients with triple-negative breast cancer.
Expert insights on the practical application of immunotherapy in early-stage NSCLC
Watch an expert discuss the key clinical questions surrounding currently approved RET inhibitors in NSCLC.
In this symposium, three lung cancer specialists share their insights on TROP2-targeted ADCs in NSCLC
Two experts discuss evolving immunotherapy standards of care in advanced/recurrent endometrial cancer.
A multidisciplinary team and a patient advocate discuss antibody–drug conjugate (ADC) related toxicities in metastatic breast cancer.
A multidisciplinary team and a patient advocate discuss use of PARP inhibitors in mCRPC
Watch two experts discuss HPV-related disease, vaccination scheduling and strategies to increase uptake.
touchONCOLOGY is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events
Expert insights on new and emerging approaches to optimize the management of steroid-refractory cGvHD.
Three experts discuss data presented at ASH 2024 on BCMA-targeting agents in multiple myeloma.
Three expert haematologists discuss current and emerging treatments for ITP as well as the disease burden.
Experts discuss the role of RAS mutations in solid tumours and how they may be targeted to improve outcomes.
Watch a lung cancer expert discuss the latest data for ADCs in NSCLC and their implications for clinical practice.
Leading experts discuss the impact of ITP on patients and review current and emerging treatment strategies.
Three experts share insights into the treatment and care of patients with NF1 from childhood to adulthood.
An oncologist, urologist and oncology nurse consider the use of perioperative immunotherapy in MIBC.
Hear expert insights on recurrence risk in early-stage melanoma and possible treatment approaches
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.